Bracken Sonali J, Adami Alexander J, Szczepanek Steven M, Ehsan Mohsin, Natarajan Prabitha, Guernsey Linda A, Shahriari Neda, Rafti Ektor, Matson Adam P, Schramm Craig M, Thrall Roger S
Department of Immunology, University of Connecticut Health Center, Farmington, Conn., USA.
Int Arch Allergy Immunol. 2015;166(4):243-58. doi: 10.1159/000381058. Epub 2015 Apr 28.
Allergic asthma is a major cause of worldwide morbidity and results from inadequate immune regulation in response to innocuous, environmental antigens. The need exists to understand the mechanisms that promote nonreactivity to human-relevant allergens such as house dust mite (HDM) in order to develop curative therapies for asthma. The aim of our study was to compare the effects of short-, intermediate- and long-term HDM administration in a murine asthma model and determine the ability of long-term HDM exposure to suppress allergic inflammation.
C57BL/6 mice were intranasally instilled with HDM for short-term (2 weeks), intermediate-term (5 weeks) and long-term (11 weeks) periods to induce allergic airway disease (AAD). The severity of AAD was compared across all stages of the model via both immunological and pulmonary parameters.
Short- and intermediate-term HDM exposure stimulated the development of AAD that included eosinophilia in the bronchoalveolar lavage fluid (BALF), pronounced airway hyperreactivity (AHR) and evidence of lung inflammation. Long-term HDM exposure promoted the suppression of AAD, with a loss of BALF eosinophilia and AHR despite persistent mononuclear inflammation in the lungs. Suppression of AAD with long-term HDM exposure was associated with an increase in both Foxp3+ regulatory T cells and IL-10-positive alveolar macrophages at the site of inflammation.
This model recapitulates the key features of human asthma and may facilitate investigation into the mechanisms that promote immunological tolerance against clinically relevant aeroallergens.
过敏性哮喘是全球发病的主要原因,是机体对无害环境抗原的免疫调节不足所致。为了开发哮喘的治疗方法,有必要了解促进对人类相关过敏原(如屋尘螨(HDM))无反应性的机制。我们研究的目的是比较在小鼠哮喘模型中短期、中期和长期给予HDM的效果,并确定长期暴露于HDM抑制过敏性炎症的能力。
将C57BL/6小鼠经鼻内滴注HDM,分别进行短期(2周)、中期(5周)和长期(11周)诱导过敏性气道疾病(AAD)。通过免疫和肺部参数在模型的所有阶段比较AAD的严重程度。
短期和中期HDM暴露刺激了AAD的发展,包括支气管肺泡灌洗液(BALF)中的嗜酸性粒细胞增多、明显的气道高反应性(AHR)和肺部炎症证据。长期HDM暴露促进了AAD的抑制,尽管肺部持续存在单核细胞炎症,但BALF嗜酸性粒细胞和AHR消失。长期HDM暴露对AAD的抑制与炎症部位Foxp⁺调节性T细胞和IL-10阳性肺泡巨噬细胞的增加有关。
该模型概括了人类哮喘的关键特征,可能有助于研究促进对临床相关气传过敏原免疫耐受的机制。